AHPA
Avista Public Acquisition Corp. II [AHPA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AHPA Stock Summary
In the News
AHPA Financial details
Company Rating
Neutral
Market Cap
705.17M
Income
-50.62M
Revenue
34.16M
Book val./share
3.14
Cash/share
0.87
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
31.94
P/B
1.78
P/C
-
P/FCF
-
Quick Ratio
5.32
Current Ratio
5.59
Debt / Equity
0.08
LT Debt / Equity
0.07
-
-
EPS (TTM)
-0.51
EPS next Y
-
EPS next Q
-
EPS this Y
96.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
33.56%
Revenue last 5Y
13.28%
Revenue Q/Q
-11.96%
EPS Q/Q
-12.5%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
888275%
ROE
2244104%
ROC
9374.86%
Gross Margin
66%
Oper. Margin
16620141%
Profit Margin
16619949%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.83-10.5
52W High
-
52W Low
-
RSI
-
Rel Volume
0.91
Avg Volume
71.05K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
AHPA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.16 | 0.2 | 0.42 | 0.69 | 0.34 | |
| Net income per share | -0.12 | -0.15 | -0.33 | -0.26 | -0.51 | |
| Operating cash flow per share | -0.05 | 0.03 | -0.07 | -0.04 | 0.02 | |
| Free cash flow per share | -0.05 | 0.02 | -0.12 | -0.24 | 0.01 | |
| Cash per share | 0 | -0.02 | -0.17 | 1.03 | 0.87 | |
| Book value per share | 1.9 | 2.05 | 2.84 | 4 | 3.16 | |
| Tangible book value per share | -0.28 | -0.31 | -0.31 | 1.06 | 0.75 | |
| Share holders equity per share | 1.9 | 2.05 | 2.84 | 4 | 3.16 | |
| Interest debt per share | 0 | 0.02 | 0.17 | 0.3 | 0.26 | |
| Market cap | 1.12B | 1.12B | 826.12M | 307.14M | 615.04M | |
| Enterprise value | 1.12B | 1.13B | 853.82M | 299.55M | 624.25M | |
| P/E ratio | -82.47 | -63.83 | -30.55 | -13.75 | -12.15 | |
| Price to sales ratio | 61.18 | 48.16 | 23.77 | 5.2 | 18 | |
| POCF ratio | -215.72 | 309.66 | -145.65 | -85.63 | 262.06 | |
| PFCF ratio | -205.62 | 600.56 | -84.8 | -14.8 | 874.88 | |
| P/B Ratio | 5.14 | 4.76 | 3.53 | 0.9 | 1.96 | |
| PTB ratio | 5.14 | 4.76 | 3.53 | 0.9 | 1.96 | |
| EV to sales | 61.18 | 48.39 | 24.57 | 5.07 | 18.27 | |
| Enterprise value over EBITDA | -531.11 | -106.35 | -47.2 | -23.02 | -12.55 | |
| EV to operating cash flow | -215.72 | 311.09 | -150.53 | -83.51 | 265.98 | |
| EV to free cash flow | -205.62 | 603.34 | -87.64 | -14.43 | 887.98 | |
| Earnings yield | -0.01 | -0.02 | -0.03 | -0.07 | -0.08 | |
| Free cash flow yield | 0 | 0 | -0.01 | -0.07 | 0 | |
| Debt to equity | 0 | 0.01 | 0.06 | 0.08 | 0.08 | |
| Debt to assets | 0 | 0.01 | 0.05 | 0.06 | 0.06 | |
| Net debt to EBITDA | 0 | -0.49 | -1.53 | 0.58 | -0.19 | |
| Current ratio | 1.27 | 1.17 | 1.1 | 4.8 | 4.11 | |
| Interest coverage | 0 | -5.12K | -5.09K | 45.4 | 0 | |
| Income quality | 0.38 | -0.21 | 0.21 | 0.16 | -0.05 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.47 | 0.44 | 0.49 | 0.42 | 0.98 | |
| Research and developement to revenue | 0.72 | 1.07 | 1.13 | 0.82 | 1.65 | |
| Intangibles to total assets | 0.95 | 0.92 | 0.85 | 0.6 | 0.6 | |
| Capex to operating cash flow | 0.05 | -0.48 | 0.72 | 4.79 | -0.7 | |
| Capex to revenue | -0.01 | -0.08 | -0.12 | -0.29 | -0.05 | |
| Capex to depreciation | -0.02 | -0.13 | -0.25 | -0.94 | -0.08 | |
| Stock based compensation to revenue | 0.36 | 0.39 | 0.43 | 0.31 | 0.73 | |
| Graham number | 2.25 | 2.66 | 4.57 | 4.85 | 6 | |
| ROIC | -0.06 | -0.08 | -0.11 | -0.06 | -0.15 | |
| Return on tangible assets | -1.11 | -0.71 | -0.61 | -0.13 | -0.31 | |
| Graham Net | -0.33 | -0.43 | -0.74 | 0.37 | 0.02 | |
| Working capital | 1.66M | 2.37M | 1.97M | 98.93M | 71.79M | |
| Tangible asset value | -31.91M | -35.09M | -25.99M | 90.15M | 75.14M | |
| Net current asset value | -36.34M | -43.19M | -47.62M | 45.11M | 7.5M | |
| Invested capital | 0 | 0.01 | 0.06 | 0.08 | 0.08 | |
| Average receivables | 0 | 11.82M | 18.51M | 25.71M | 17.07M | |
| Average payables | 0 | 637.5K | 1.7M | 2.95M | 3.69M | |
| Average inventory | 0 | 1.3M | 8.22M | 6.93M | 0 | |
| Days sales outstanding | 154.9 | 249.03 | 222.02 | 187.14 | 41.07 | |
| Days payables outstanding | 0 | 0 | 71.3 | 66.73 | 82.58 | |
| Days of inventory on hand | 0 | 0 | 337.76 | 0 | 0 | |
| Receivables turnover | 2.36 | 1.47 | 1.64 | 1.95 | 8.89 | |
| Payables turnover | 0 | 0 | 5.12 | 5.47 | 4.42 | |
| Inventory turnover | 0 | 0 | 1.08 | 0 | 0 | |
| ROE | -0.06 | -0.07 | -0.12 | -0.07 | -0.16 | |
| Capex per share | 0 | -0.02 | -0.05 | -0.2 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.38 | 0.17 | 0.07 | 0.05 | 0.05 | |
| Net income per share | 0.07 | -0.06 | -0.15 | -0.16 | -0.14 | |
| Operating cash flow per share | -0.03 | 0.28 | -0.1 | -0.06 | -0.09 | |
| Free cash flow per share | -0.12 | 0.28 | -0.11 | -0.07 | -0.09 | |
| Cash per share | 0.95 | 1.15 | 1.04 | 0.97 | 0.87 | |
| Book value per share | 3.66 | 3.44 | 3.36 | 3.25 | 3.14 | |
| Tangible book value per share | 0.97 | 0.93 | 0.88 | 0.82 | 0.75 | |
| Share holders equity per share | 3.66 | 3.44 | 3.36 | 3.25 | 3.14 | |
| Interest debt per share | 0.27 | 0.25 | 0.27 | 0.26 | 0.26 | |
| Market cap | 336.06M | 364.9M | 500.45M | 518.51M | 618M | |
| Enterprise value | 328.47M | 367.85M | 505.98M | 523.44M | 627.2M | |
| P/E ratio | 12.32 | -14.95 | -8.49 | -8.24 | -10.99 | |
| Price to sales ratio | 9.51 | 21.57 | 72.05 | 94.67 | 128.16 | |
| POCF ratio | -126.01 | 13.18 | -49.94 | -83.66 | -67.76 | |
| PFCF ratio | -28.98 | 13.29 | -46.19 | -77.53 | -66.97 | |
| P/B Ratio | 0.98 | 1.07 | 1.5 | 1.6 | 1.96 | |
| PTB ratio | 0.98 | 1.07 | 1.5 | 1.6 | 1.96 | |
| EV to sales | 9.29 | 21.74 | 72.84 | 95.57 | 130.07 | |
| Enterprise value over EBITDA | 25.44 | -72.36 | -31.5 | -30.94 | -38.51 | |
| EV to operating cash flow | -123.17 | 13.29 | -50.49 | -84.45 | -68.76 | |
| EV to free cash flow | -28.32 | 13.4 | -46.7 | -78.27 | -67.97 | |
| Earnings yield | 0.02 | -0.02 | -0.03 | -0.03 | -0.02 | |
| Free cash flow yield | -0.03 | 0.08 | -0.02 | -0.01 | -0.01 | |
| Debt to equity | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |
| Debt to assets | 0.06 | 0.06 | 0.07 | 0.07 | 0.06 | |
| Net debt to EBITDA | -0.59 | -0.58 | -0.34 | -0.29 | -0.57 | |
| Current ratio | 4.8 | 5.59 | 4.78 | 4.26 | 4.11 | |
| Interest coverage | -15.42 | 6.38 | 0 | 0 | 0 | |
| Income quality | 0.19 | -4.54 | 0.68 | 0.39 | 0.65 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.29 | 0.48 | 1.26 | 1.55 | 1.63 | |
| Research and developement to revenue | 0.37 | 0.81 | 2.03 | 2.53 | 3.06 | |
| Intangibles to total assets | 0.6 | 0.6 | 0.61 | 0.62 | 0.6 | |
| Capex to operating cash flow | 3.35 | -0.01 | 0.08 | 0.08 | 0.01 | |
| Capex to revenue | -0.25 | -0.01 | -0.12 | -0.09 | -0.02 | |
| Capex to depreciation | -0.96 | -0.05 | -0.17 | -0.1 | -0.02 | |
| Stock based compensation to revenue | 0.32 | 0.36 | 0.94 | 1.15 | 1.23 | |
| Graham number | 2.45 | 2.18 | 3.34 | 3.39 | 3.15 | |
| ROIC | 0.02 | -0.02 | -0.04 | -0.04 | -0.04 | |
| Return on tangible assets | 0.04 | -0.04 | -0.09 | -0.11 | -0.09 | |
| Graham Net | 0.33 | 0.43 | 0.38 | 0.34 | 0.02 | |
| Working capital | 98.93M | 99.4M | 91.7M | 81.79M | 71.79M | |
| Tangible asset value | 90.15M | 92.47M | 87.91M | 81.8M | 75.14M | |
| Net current asset value | 45.11M | 48.84M | 44.51M | 39.69M | 7.5M | |
| Invested capital | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |
| Average receivables | 17.51M | 16.05M | 5.22M | 7.37M | 4.99M | |
| Average payables | 4.64M | 2.73M | 2.42M | 2.43M | 3.46M | |
| Average inventory | -2.36M | 0 | 0.5 | 1 | 0.5 | |
| Days sales outstanding | 77.13 | 9.68 | 111.57 | 100.85 | 71.75 | |
| Days payables outstanding | 103.71 | 51.19 | 43.69 | 46.47 | 80.46 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 1.17 | 9.3 | 0.81 | 0.89 | 1.25 | |
| Payables turnover | 0.87 | 1.76 | 2.06 | 1.94 | 1.12 | |
| Inventory turnover | 0 | 0 | 4.86M | 4.84M | 0 | |
| ROE | 0.02 | -0.02 | -0.04 | -0.05 | -0.04 | |
| Capex per share | -0.1 | 0 | -0.01 | 0 | 0 |
AHPA Frequently Asked Questions
What is Avista Public Acquisition Corp. II stock symbol ?
Avista Public Acquisition Corp. II is a US stock , located in New york of Ny and trading under the symbol AHPA
What is Avista Public Acquisition Corp. II stock quote today ?
Avista Public Acquisition Corp. II stock price is $- today.
Is Avista Public Acquisition Corp. II stock public?
Yes, Avista Public Acquisition Corp. II is a publicly traded company.
Company Profile
- Volume Average 71.05K
- Market Capitalization 705.17M
- Headquarters New York,NY,US
- IPO Date 2021-09-30
Avista Public Acquisition Corp. II does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. The company focuses on pursuing businesses in the healthcare industry. Avista Public Acquisition Corp. II was incorporated in 2021 and is based in New York, New York.
